Table 1 Patient characteristics at baseline and 5-year follow-up
Characteristics* | Patients with diabetes | Patients without diabetes |
|---|---|---|
Baseline | (n =35) | (n =31) |
Age (years) | 54 (31–73) | 51 (35–77) |
Female/Male (n) | 22/13 | 19/12 |
Duration of CTS (months) | 24 (8–96) | 36 (12–180) |
Duration of diabetes (years) | 15 (1–43) | – |
BMI (kg/m2) | 28.1 (18.8 – 36.7) | 26.3 (20–36.2) |
HbA1c (mmol/mol) | 50 (29 – 85) | 25 (18 – 32) |
HbA1c (%) | 6.7 (4.8 – 9.9) | 4.4 (3.8 – 5.1) |
Median nerve, SNCV | 20 (0–39) | 25 (0–35) |
Median nerve, DML | 5.9 (3.8-10.0) | 5.2 (3.3-8.4) |
Follow-up, 5 years | (n =27) | (n =30) |
Baseline to Follow-up (months) | 68 (59 – 82) | 64 (59–69) |
BMI (kg/m2) | 28.7 (17 – 38.1) | 25.7 (20.4 – 40.8) |
HbA1c (mmol/mol) | 53 (38 – 91) | 35 (23 – 49) |
HbA1c (%) | 7 (5.6 – 10.5) | 5.4 (4.3 – 6.6) |